Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

From uremic toxins to cognitive decline: Elucidating the pathophysiology of mild cognitive impairment in chronic kidney disease

Objective

Chronic kidney disease (CKD) is a global healthy priority, affecting 850 million people worldwide, with up to 60% having cognitive impairment. Mild Cognitive Impairment in CKD (MCI-CKD), despite its high risk of progression to dementia, is under-recognised, under-researched and poorly managed. The underlying mechanisms and key players of MCI-CKD remain poorly understood, hindering early diagnosis and effective interventions. The multidisciplinary MOMENTUM project will integrate clinical, mechanistic and patient-centred perspectives to address these unmet needs by elucidating the pathophysiology of MCI-CKD – with special focus on Uremic Toxins (UTs) – and by identifying reliable biomarkers of MCI-CKD diagnosis and progression. MOMENTUM aims to: (i) investigate the association between circulating UT levels, cognitive impairment and brain alterations in MCI-CKD through a multicentre cross-sectional and longitudinal study; (ii) assess blood-brain barrier (BBB) integrity in vitro and ex vivo, linking UT activity and BBB injury with cerebral dysfunction; (iii) establish causal links between UT exposure, brain injury and neurocognitive outcomes in zebrafish and murine CKD models, by mechanistic analyses not feasible in humans; (iv) investigate the role of the gut microbiome in BBB disruption and cognitive decline; (v) address ethical, legal and social issues, and foster active engagement of patients living with MCI-CKD, clinicians and other stakeholders. MOMENTUM will allow the first comprehensive characterisation of MCI-CKD, generating actionable knowledge for improved clinical outcomes. It will enable and inform improvements of patients’ clinical management, aligning with EU priorities to improve sustainability and quality of healthcare. MOMENTUM will ultimately yield new opportunities for MCI-CKD early diagnosis and targeted interventions, with substantial benefits for patients, caregivers and health systems.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-RIA - HORIZON Research and Innovation Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-HLTH-2025-01

See all projects funded under this call

Coordinator

BIOGEM scarl
Net EU contribution
€ 954 862,50
Address
Via Camporeale, area P.I.P.
83031 Ariano Irpino (Av)
Italy
Region
Sud Campania Avellino
Activity type
Research Organisations
Links
Total cost
€ 954 862,50

Participants (12)